Aizenshtein E - Search Results

1

Practical aspects in the use of passive immunization as an alternative to attenuated viral vaccines.

Aizenshtein E, Yosipovich R, Kvint M, Shadmon R, Krispel S, Shuster E, Eliyahu D, Finger A, Banet-Noach C, Shahar E, Pitcovski J. Aizenshtein E, et al. Vaccine. 2016 May 11;34(22):2513-8. doi: 10.1016/j.vaccine.2016.03.051. Epub 2016 Apr 11. Vaccine. 2016. PMID: 27079929

2

Targeted microbeads for attraction and induction of specific innate immune response in the tumor microenvironment.

Shahar E, Gorodetsky R, Gaberman E, Aizenshtein E, Pitcovski J. Shahar E, et al. Among authors: aizenshtein e. Vaccine. 2010 Oct 21;28(45):7279-87. doi: 10.1016/j.vaccine.2010.08.083. Epub 2010 Sep 8. Vaccine. 2010. PMID: 20831916

3

Immunological complex for enhancement of innate immune response in passive vaccination.

Aizenshtein E, Pinchasov Y, Morag E, Leitner G, Shpanir Y, Reimond D, Pitcovski J. Aizenshtein E, et al. Vaccine. 2013 Jan 11;31(4):626-31. doi: 10.1016/j.vaccine.2012.11.058. Epub 2012 Dec 2. Vaccine. 2013. PMID: 23212028

4

Overcoming the susceptibility gap between maternal antibody disappearance and auto-antibody production.

Yosipovich R, Aizenshtein E, Shadmon R, Krispel S, Shuster E, Pitcovski J. Yosipovich R, et al. Among authors: aizenshtein e. Vaccine. 2015 Jan 9;33(3):472-8. doi: 10.1016/j.vaccine.2014.10.043. Epub 2014 Nov 4. Vaccine. 2015. PMID: 25444785

5

Mannosamine-biotin as a novel masking agent for coating IgG for immune response silencing and augmentation of antibody-antigen interaction.

Vaya J, Aizenshtein E, Khatib S, Gefen T, Fassler M, Musa R, Krispel S, Pitcovski J. Vaya J, et al. Among authors: aizenshtein e. Vaccine. 2009 Nov 16;27(49):6869-76. doi: 10.1016/j.vaccine.2009.09.010. Epub 2009 Sep 16. Vaccine. 2009. PMID: 19765399

6

Coated cross-species antibodies by mannosamine-biotin adduct confer protection against snake venom without eliciting humoral immune response.

Gefen T, Pitcovski J, Vaya J, Khatib S, Krispel S, Heller ED, Gaberman E, Gorodetsky R, Aizenshtein E. Gefen T, et al. Among authors: aizenshtein e. Vaccine. 2010 Nov 29;28(51):8197-202. doi: 10.1016/j.vaccine.2010.09.032. Epub 2010 Sep 25. Vaccine. 2010. PMID: 20875497

7

Melanoma antigens and related immunological markers.

Pitcovski J, Shahar E, Aizenshtein E, Gorodetsky R. Pitcovski J, et al. Among authors: aizenshtein e. Crit Rev Oncol Hematol. 2017 Jul;115:36-49. doi: 10.1016/j.critrevonc.2017.05.001. Epub 2017 May 6. Crit Rev Oncol Hematol. 2017. PMID: 28602168 Review.

8

Modulating the innate immune activity in murine tumor microenvironment by a combination of inducer molecules attached to microparticles.

Shahar E, Gorodetsky R, Aizenshtein E, Lalush L, Pitcovski J. Shahar E, et al. Among authors: aizenshtein e. Cancer Immunol Immunother. 2015 Sep;64(9):1137-49. doi: 10.1007/s00262-015-1719-z. Epub 2015 Jun 2. Cancer Immunol Immunother. 2015. PMID: 26031575

9

Formation of multimeric antibodies for self-delivery of active monomers.

Dekel Y, Machluf Y, Gefen T, Eidelshtein G, Kotlyar A, Bram Y, Shahar E, Reslane F, Aizenshtein E, Pitcovski J. Dekel Y, et al. Among authors: aizenshtein e. Drug Deliv. 2017 Nov;24(1):199-208. doi: 10.1080/10717544.2016.1242179. Drug Deliv. 2017. PMID: 28156181 Free PMC article.

10

The impact of PEGylation on protein immunogenicity.

Gefen T, Vaya J, Khatib S, Harkevich N, Artoul F, Heller ED, Pitcovski J, Aizenshtein E. Gefen T, et al. Among authors: aizenshtein e. Int Immunopharmacol. 2013 Feb;15(2):254-9. doi: 10.1016/j.intimp.2012.12.012. Epub 2013 Jan 7. Int Immunopharmacol. 2013. PMID: 23306102

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page